Prevalence and incidence of chronic complications and mortality in a cohort of type 2 diabetic patients in Spain

Primary Care Diabetes

Volumn 2, Issue 3, 2008, Pages 135-140

  Mundet, Xavier ^a   Pou, Antonia ^a   Piquer, Nuria ^a   Sanmartin, Maria Isabel Fernandez ^a   Tarruella, Marc ^a   Gimbert, Rosa ^a   Farrus, Montserrat ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Diabetes mellitus; Diabetic complications; Incidence; Macrovascular; Microvascular

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; DIABETES MELLITUS; GENERAL PRACTITIONER; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PREVALENCE; PROSPECTIVE STUDY; SEXUAL DEVELOPMENT; SPAIN;

AGE OF ONSET; AGED; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHYSICIANS, FAMILY; PREVALENCE; PROSPECTIVE STUDIES; SEX CHARACTERISTICS; SPAIN;

EID: 51049099579     PISSN: 17519918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcd.2008.05.001     Document Type: Article

References (32)

1. The World Health Report: life in 21st Century, Ginebra 1991.
2. Goday A., and Serrano Rios M. Epidemiologia de la Diabetes Mellitus en España. Revisión crítica y nuevas prespectivas. Med. Clin. (Barc.) 41 (1994) 301-304
3. Medrano M.J., Cerrato E., Boix R., and Delgado-Rodriguez M. Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales. Med. Clin. (Barc.) 1241 (2005) 606-612
4. Morgan C.L., Curie C.J., and Peters J.R. Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care 23 (2003) 1103-1107
5. Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with Type 2 diabetes. N. Engl. J. Med. 348 (2003) 383-393
6. American Diabetes Association. Clinical Practice Recommendation 2006. Diabetes Care 29 (2006) S1-S135
7. GEDAPS. Guia para el tratamiento de la Diabetes Mellitus tipo 2 en Atención Primaria. Harcourt, Barcelona 2004.
8. Nazimek-Siewniak B., Moczulski D., and Grzeszczak W. Risk of macrovascular and microvascular complications in type 2 diabetes. Results of longitudinal study design. J. Diabetes Complications 16 (2002) 271-276 9
9. C. Brotons, R. Ciurana, A. Franzi, R.M. Garcia, A. Isach, J. Tobías, J. Vilaseca. Hipercolesterolemia, Guia Pràctica clínica. Intitut Català de la Salut 2001.
10. McAlpine R., Morris A.D., Emslie-Smith A., et al. The annual inicdence of diabetic complications in population of patients with Type 1 and Type 2 diabetes. Diabetic Med. 22 (2004) 348-352
11. Younis N., Broadbent D.M., Vora J.P., and Harding S.P. Incidence of sight-treatening retinopathy with type 2 diabetes in the Liverpool Diabetic Eye study: a cohort study. Lancet 361 (2003) 195-200
12. Fox C.S., Coady S., Sorlie P.D., et al. Trends in Cardiovascular complications of diabetes. JAMA 292 (2004) 2495-2499
13. Artegoitia J.M., Larrañaga M.I., Rodríguez J.L., et al. Incidente, prevalence and coronary heart disease risk level in knowm Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia 46 (2003) 899-909
14. Liebl A., Neiss A., Spannheimer A., et al. Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany-results from the CODE-2 study. Exp. Clin. Endocrinol. Diabetes 110 (2002) 10-16
15. Grimaldi A., Grange V., Allannic H., et al. Epidemiological analysis of patients with Type 2 diabetes in France. J. Diabetes Complications 14 (2000) 242-249
16. Farnkvist L.M., and Lundiabetesan B.M. Outcomes of diabetes care: a population-based study. Int. J. Quality Health Care 15 (2003) 301-307
17. Mundet X., Carmona F., Gussinyer P., et al. Complicaciones crónicas de la Diabetes Mellitus tipo 2. Evolución tras 5 años de seguimiento. Aten. Primaria 25 (2000) 405-411
18. Mur T., Franch J., Morató J., et al. Macroangiopatia en la diabetes tipo 2. Aten. Primaria 16 (1995) 67-72
19. UK Prospective Diabetes study 23: risk factors for coronary artery disease in non-insulin dependent diabetes. Br. Med. J. 316 (1998) 823-828
20. Turner R.C., Cull C.A., Frighi V., and Holman R.R. UKPDS 49 Glycaemic control with diet, sulphonylurea, metformin and insulin therapy in patients with type 2 diabetes: progressive requirement for multiple therapies. JAMA 281 (1999) 2005-2012
21. Ritz E., and Orth S.R. Nephropathy in patients with type 2 diabetes mellitus. N. Engl. J. Med. 341 (1999) 1127-1133
22. Kuusisto J., Mykkanen L., Pyorala K., and Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43 (1994) 960-967
23. Lehto S., Ronnemaa T., Haffner S.M., et al. Dislipemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 48 (1997) 1354-1359
24. Khaw K., Wareham N., Luben R., et al. Glycated haemoglobina,diabetes, and mortality in men in Norfolk cohort of European prospective Investigation of Cancer and nutrition (EPIC-Norfolk). Br. Med. J. 322 (2001) 1-6
25. Wei M., Gaskill S.P., Haffner S.M., and Stern M.P. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21 (1998) 1167-1172
26. Selvin E., Marinopoulos S., Berkenblit G., et al. Meta-analysis: glycosilated hemoglobin and cardiovascular disease in diabetes mellitus. Ann. Intern. Med. 141 (2004) 421-431
27. Fox C.S., Sullivan L., D'Agostino R.B., and Wilson P.W. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart study. Diabetes Care 27 (2004) 704-708
28. Thomas R.J., Palumbo P.J., Melton L.J., et al. Trends in the mortality burden associated with diabetes mellitus. A population-based study in Rochester, Minn, 1970-1994. Arch. Intern. Med. 163 (2003) 445-451
29. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors amb 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16 (1993) 434-444
30. Cusik M., Meleth A.D., Agron E., et al. Associations of mortality and diabetes complications in patients with type 1 and Type 2 diabetes. Early Treatment Diabetic Retinopathy Study report no 27. Diabetes Care 28 (2005) 617-625
31. P. Roura P. Evaluación de los indicadores de calidad asistencial al diabético tipo 2 en el ámbito urbano i no urbano. 10 años de experiencia de programa GEDAPS. Tesis Doctoral. Universidad Autónoma de Barcelona, Barcelona 2006.
32. Wandell P.E., and Gafvels C. Patients with type 2 diabetes aged 35-64 years at four primary health centres in Stockholm Country, Sweden prevalence and complications in relation to gender and socio-economics status. Diabetes Res. Clin. Prac. 63 (2004) 195-203